Optiver Holding
COGT icon

Optiver Holding’s Cogent Biosciences COGT Stock Holding History

Optiver Holding’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$20.1K Sell
522
-97
-16% -$3.58K ﹤0.01% 1099
2025
Q4 		$22K Sell
619
-129
-17% -$3.63K ﹤0.01% 1015
2025
Q3 		$10.7K Buy
+748
New +$8.86K ﹤0.01% 1253

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Optiver Holding's COGT Position: Q1 2026 in Review

Optiver Holding reduced its Cogent Biosciences (COGT) stake by 16% in Q1 2026, selling an estimated $3.58K and leaving 522 shares worth $20.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1099.

Optiver Holding first reported a position in COGT in Q3 2025 and has held it in 3 quarters since. The position peaked at $22K in Q4 2025. 305 funds tracked by Wall St. Rank hold COGT as of Q1 2026.

  • Optiver Holding held 522 shares of Cogent Biosciences worth $20.1K as of Q1 2026.
  • Optiver Holding sold 97 Cogent Biosciences shares in Q1 2026, an estimated $3.58K.
  • Cogent Biosciences made up ﹤0.01% of Optiver Holding's portfolio in Q1 2026, its #1099 holding.
  • Optiver Holding first reported a position in Cogent Biosciences in Q3 2025 and has held it in 3 quarters since.
  • Optiver Holding's Cogent Biosciences position peaked at $22K in Q4 2025.
  • 305 funds tracked by Wall St. Rank held Cogent Biosciences as of Q1 2026.

Based on Optiver Holding's 13F filing for Q1 2026, filed 15 May 2026.